Wang Xi について
Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China について
Wang Xi について
Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China について
Guo Zheng について
Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China について
Guo Zheng について
Xuzhou Center for Disease Control and Prevention, Xuzhou, China について
Zhu Huanhuan について
Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China について
Zhu Huanhuan について
Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China について
Xin Junyi について
Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China について
Xin Junyi について
Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China について
Yuan Lin について
Department of Urology, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China について
Qin Chao について
Department of Urology, The First Affiliated Hospital of Nanjing Medicial University, Nanjing, China について
Wang Meilin について
Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China について
Wang Meilin について
Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China について
Zhang Zhengdong について
Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China について
Zhang Zhengdong について
Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China について
Wang Yunyan について
Department of Urology, The Affiliated Huai’an No. 1 Hospital of Nanjing Medical University, Huai’an, China について
Chu Haiyan について
Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China について
Chu Haiyan について
Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China について
データベース について
浸潤 について
mRNA について
遺伝子 について
層別 について
遺伝子発現 について
膀胱腫瘍 について
バイオマーカー について
スプライシング因子 について
腫瘤形成 について
症例対照研究 について
一塩基多型 について
遺伝的変異 について
候補遺伝子 について
差次的遺伝子発現 について
スプライシング因子 について
遺伝的変異 について
RBFOX3 について
膀胱癌の感受性 について
分子疫学 について
発癌機序・因子 について
遺伝的変異 について
スプライシング因子 について
遺伝子 について
遺伝的変異 について
膀胱癌 について
感受性 について